Skip to main content
32°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
HLN
)
9.660
-0.060 (-0.62%)
Official Closing Price
Updated: 5:00 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about HLN
< Previous
1
2
3
Next >
What's Going On With Kenvue Stock Monday?
October 21, 2024
Kenvue Inc. (NYSE:KVUE) shares are moving higher Monday following a report suggesting activist investor Starboard Value has acquired a stake in the company.
Via
Benzinga
Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies
October 21, 2024
Elf Beauty appeared to rally along with KVUE on Monday.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice
October 11, 2024
Sanofi is negotiating a potential sale of a 50% stake in its consumer health unit, Opella, to Clayton Dubilier & Rice. The deal, valued at $16.4 billion, could help Sanofi sharpen its focus on...
Via
Benzinga
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
October 01, 2024
Pfizer has divested a $3.3 billion stake in Haleon, reducing its holding in the British consumer healthcare company.
Via
Benzinga
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms are bidding for the unit, with the spinoff expected by Q4 2024. Banks...
Via
Benzinga
Top 2 Risk Off Stocks That May Implode In August
August 09, 2024
Via
Benzinga
Current Analysis: Haleon
March 12, 2024
Haleon (HLN) is one of the largest consumer health companies in the world. Over the past year, Haleon PLC share price rose 13.8% from $7.60 to $8.66 as of Tuesday’s market close.
Via
Talk Markets
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
Stock spinoffs are a unique opportunity to pick up unloved, unwanted businesses but patience is often needed before buying in.
Via
InvestorPlace
Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M
June 26, 2024
Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories SA for £500 million ($632 million). This strategic move allows Haleon to focus on growth...
Via
Benzinga
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
June 26, 2024
Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.
Via
Benzinga
GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
May 17, 2024
GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advil painkillers.
Via
Benzinga
Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
March 18, 2024
Pfizer to reduce stake in Haleon to approximately 24% following earlier divestment announcement. Offer price per share to be revealed post book-building process by Haleon.
Via
Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Haleon Earnings Preview
February 28, 2024
Via
Benzinga
Peering Into Haleon's Recent Short Interest
January 16, 2024
Via
Benzinga
Advil Maker Haleon Expects Higher 2024 Revenue After Strong 2023 Earnings, Stock Soars
February 29, 2024
Haleon reports FY 2023 revenue growth of 4.1% to £11.3 billion ($14.03 billion), missing consensus. Adjusted operating profit rises 10.4% to £2.55 billion. CEO Brian McNamara outlines solid financial...
Via
Benzinga
Robitussin Recall 2024: What to Know About the New Cough Syrup Recalls
January 26, 2024
A Robitussin recall is underway for two of the company's products after discovering microbial contamination of its cough syrups.
Via
InvestorPlace
Robitussin Recall: Here Are The Products Impacted And What You Need To Know
January 25, 2024
Haleon PLC (NYSE: HLN) announced a product recall of some of its Robitussin brand cough syrups. What Happened: A microbial contamination in Robitussin cough syrups could potentially cause...
Via
Benzinga
GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
January 17, 2024
GSK sells 300M shares in Haleon at £326/share, raising £978M. GSK to retain 4.2% stake.
Via
Benzinga
How Is The Market Feeling About Haleon?
December 28, 2023
Via
Benzinga
Looking Into Haleon's Recent Short Interest
December 01, 2023
Via
Benzinga
How Is The Market Feeling About Haleon?
November 15, 2023
Via
Benzinga
A Look Into Haleon Inc's Price Over Earnings
October 30, 2023
Via
Benzinga
How Is The Market Feeling About Haleon?
October 24, 2023
Via
Benzinga
Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B
November 16, 2023
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over...
Via
Benzinga
7 Healthcare Stocks to invest in for a Healthy Future
October 20, 2023
Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners.
Via
InvestorPlace
GSK: Pharma Giant Prioritizing Shareholder Dividends
October 13, 2023
A good hunting ground for dividend stocks is often companies from which Wall Street wants to see strong performance in the short-term, while its long-term prospects are actually what are most bright.
Via
Talk Markets
Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
October 06, 2023
Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger
Via
Benzinga
GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B
October 06, 2023
GSK Plc (NYSE: GSK) said it raised £885.6 million (
Via
Benzinga
How Is The Market Feeling About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)?
October 05, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.